Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris.

Saved in:
Bibliographic Details
Title: Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris.
Authors: Koschitzky, Merav1,2 (AUTHOR) merav.koschitzky@icahn.mssm.edu, Navrazhina, Kristina1,3 (AUTHOR) knavrazhin@mail.rockefeller.edu, Garshick, Michael S.4 (AUTHOR), Gonzalez, Juana1 (AUTHOR) jgonzalez@mail.rockefeller.edu, Han, Joseph2 (AUTHOR) joseph.han@icahn.mssm.edu, Garcet, Sandra1 (AUTHOR) sgarcet@rockefeller.edu, Krueger, James G.1 (AUTHOR) kruegej@rockefeller.edu
Source: Experimental Dermatology. Sep2022, Vol. 31 Issue 9, p1341-1351. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09066705
DOI:10.1111/exd.14582